Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Overview
Hospital History
Leadership
Awards & Honors
Newsroom
Location & Maps
Contact Us

Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Departments & Centers
Find a Doctor
How to schedule my visit
Insurance Partner & Charge List
Women's Healthcare

Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Overview
News And Information
Notice Announcement
Education Management
Overseas Exchanges
Teaching Staff

Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Overview
Invetigators
Research Team
Institutes
Paper Chase
Patents
Clinical Trials

Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Overview
Cooperative Partners
Guest Professors
Contact Us

Our Research

As China Regional Clinical Center for Obstetrics and Gynecology, WHZJU has been one of the leaders in scientific research of maternal medicine, reproductive medicine, gynecological oncology, general gynecology and undiagnosed diseases.

Home- Our Research- Clinical Trials

Clinical Trials

Study Title Brief Summary Hospital role Status
Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis The purpose of this study is to identify the recurrent rate and pregnancy rate of advanced endometriosis after laparoscopic surgery plus GnRHa goserelin acetate treatment. location Unknown status
GYNECARE PROSIMA* Procedure Versus Modified Total Pelvic Floor Reconstructive Surgery for Uterine Prolapse Stage III Pelvic Organ prolapse (a feeling of bulge in the vagina) may cause some distressing symptoms such as loss of control of the bowel or bladder, and may also cause problems with patient's sex life. The primary treatment is surgery, sometimes a mesh is placed in the pelvis to support the weakened tissues, but mesh implants can cause complications. This study is designed to determine the effectiveness and safety of GYNECARE PROSIMA* pelvic floor repair system compared with the modified total pelvic f location Unknown status
A Study of the Potential Risk Factors Linked to the Development of Severe Forms of Endometriosis This study will aim to identify genetic, medical, dietary and environmental factors associated with the development of endometrioma and/or deep infiltrating endometriosis in order to move towards early diagnosis and implementation of potential preventative measures. location Completed
Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China Human papilloma virus (HPV) infection contributes as a main causative factor to the development of invasive cervical cancer (ICC) and its precursors (cervical intraepithelial neoplasia, CIN). Currently, two prophylactic vaccines are employed for the prevention of genital HPV infection. As the prophylactic efficacy is type-restricted, determining the type-specific HPV distribution and their associations with ICC and its precursors would provide essential information in assessment of HPV vaccinati location Unknown status
A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients We will conduct a trial to determine whether paclitaxel/cisplatin (TP) as an adjuvant chemotherapy after radical surgery improve disease-free survival (DFS) and overall survival (OS), as well as the quality of life (QoL) among early-stage (FIGO stage IB-IIA) cervical cancer patients with risk factors. location Active, not recruiting
The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma This randomized trial is studying the efficacy and safety of the chemotherapy compared with radiation therapy alone as adjuvant treatment after operation in Patients with high risk and Stage I endometrial carcinoma. location Recruiting
The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma This randomized trial is studying the efficacy and safety of the hysterectomy alone compared with hysterectomy and bilateral salpingo-oophorectomy (BSO) for patients with Stage IA endometrial carcinoma. location Recruiting
Laparoscopic Sacral Colpopexy Versus Modified Total Pelvic Floor Reconstructive Surgery for Apical Prolapse Stage III-IV Pelvic Organ prolapse (a feeling of bulge in the vagina) may cause some distressing symptoms such as loss of control of the bowel or bladder, and may also cause problems with patient's sex life. The primary treatment is surgery. Sacral Colpopexy is the gold standard procedure. Now it could be done laparoscopically. Modified total pelvic floor reconstructive surgery with mesh is developed in China for Asian Women. This study is designed to determine the effectiveness and safety of Modified total location Unknown status
Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia The investigators conducted a trial to determine whether methotrexate or methotrexate/dactinomycin single-course treatment work well as multiple courses of single methotrexate chemotherapy in low-risk gestational trophoblastic neoplasia. It is not yet known whether single-course of chemotherapy is as the same effectiveness as multicourse. location Active, not recruiting
A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months The purpose of this study is to describe changes in the intensity of specific endometriosis symptoms from baseline pre-surgery to after surgery and subsequent continuous Diphereline (Triptorelin Acetate) treatment for up to 24 weeks. location Completed
Show: 10 20 50 100
Core Value

Benevolence, Dedication, Practicality, Innovation

LEARN MORE